manilatimes6h
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Income tax expense increased by $6.7 million in 2024 compared to 2023, primarily due to an increase in U.S. taxes under the ...
Innovations in core-shell nanoparticles advance drug delivery and precision medicine
A Journal of Integrative Biology explores how core-shell nanoparticles could revolutionize drug delivery systems and play a key role in advancing personalized and precision medicine.
New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle
The company has asked the U.S. patent office to reconsider patents that could prevent it from selling a new version of its ...
Repurposed amyotrophic lateral sclerosis drug becomes imaging probe to help diagnose neurodegeneration
Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative ...
New version of Merck's Keytruda faces possible patent battle, WSJ reports
Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...
Pair of studies identify promising new treatments for ulcerative colitis
According to the National Institutes of Health, between 600,000 and 900,000 Americans have ulcerative colitis, a chronic ...
FDA puts clinical hold on BioNTech’s malaria vaccine trial
The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.
manilatimes14h
Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development
Strategic collaboration harnesses GATC's proprietary Artificial Intelligence-powered, validated Multiomics Advanced Technology™ platform to rapidly optimize and derisk drug discovery and development, ...
BioNTech SE's RNA-based vaccine for malaria placed on clinical hold by FDA
BioNTech SE (NASDAQ:BNTX) said on Tuesday, that the U.S. Food and Drug Administration informed of a clinical hold on the ...
BioNTech stock falls after FDA clinical hold on malaria vaccine trial
The FDA’s clinical hold has prompted a cautious response from investors, reflecting the heightened regulatory scrutiny that BioNTech now faces. The company’s immediate focus will be on resolving the ...
Tiziana Life Sciences Ltd.: Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial
NEW YORK, March 04, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully hu ...